Amag Pharmaceuticals Inc (AMAG) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amag Pharmaceuticals inc   (NASDAQ: AMAG)


Amag Pharmaceuticals Inc's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amag Pharmaceuticals Inc's ROI in the third quarter of 2020?
Amag Pharmaceuticals Inc recorded a cumulative net loss of $-181 million during 12 months ending in the third quarter of 2020, resulting in a negative return on investment (ROI) of -31.96%.

Within the Healthcare sector 409 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 0 to 3759.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM -34.1 % -33.87 % -40.37 % -41.12 % -39.26 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 572 549 561 577 756
Return On Investment (TTM) -31.96 % -36.59 % -51.68 % -62.29 % -33.72 %
AMAG's Overall Ranking # 3759 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -7.53 % -8.36 % -10.99 % -12.64 % -7.2 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -181 -223 -344 -466 -289

AMAG Company Profile >> Back to AMAG Roi Comparisons >> See Annual AMAG Return On Investment



Return On Investment AMAG's Ranking
Within: No.
Industry # 156
Sector # 410
Overall # 3759

Return On Investment Statistics
High Average Low
22.11 %
-11.76 %
-62.29 %
(Dec 31 2014)   (Dec 31 2019)







Financial Statements
Amag Pharmaceuticals Inc's III. Quarter Investments $ 572 Millions AMAG's Balance sheet
Amag Pharmaceuticals Inc's III. Quarter Income $ 19 Millions Quarterly AMAG's Income Statement
AMAG's Income by Division See AMAG's Income by Division


AMAG Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 577 1,010 1,576 2,115 2,116
Y / Y Investment Growth -42.9 % -35.89 % -25.49 % -0.06 % 73.09 %
Net Income in Millions -468 -66 -199 -2 33
Y / Y Net Income Growth - - - - -75.87 %
Annual Return On Investment -81.09 % -6.51 % -12.65 % -0.12 % 1.55 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMAG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMAG's Competitors
Subscribers only: Roi for Amag Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AMAG's Customers

Other Ratios
AMAG's Roa AMAG's Inventory Turnover Ratio AMAG's Growth Rates AMAG's Dividend Statistics
AMAG's Profitability Ratios AMAG's Asset Turnover Ratio AMAG's Dividend Growth
AMAG's Roe AMAG's Valuation Ratios AMAG's Financial Strength Ratios AMAG's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI

Date modified: 2026-09-26T07:14:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.